Published in J Clin Invest on January 01, 1972
Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infect Immun (1980) 5.68
Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80
A population genetic framework for the study of invasive diseases caused by serotype b strains of Haemophilus influenzae. Proc Natl Acad Sci U S A (1985) 4.48
PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol (1994) 4.08
DNA repeats identify novel virulence genes in Haemophilus influenzae. Proc Natl Acad Sci U S A (1996) 3.38
Identification of immunogenic outer membrane proteins of Haemophilus influenzae type b in the infant rat model system. Infect Immun (1981) 3.37
Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease. Infect Immun (1982) 3.18
Purification and partial characterization of outer membrane proteins P5 and P6 from Haemophilus influenzae type b. Infect Immun (1985) 2.99
Cloning of chromosomal DNA from Haemophilus influenzae. Its use for studying the expression of type b capsule and virulence. J Clin Invest (1984) 2.94
Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human serum bactericidal antibody. J Clin Invest (1986) 2.91
Genetics of spontaneous, high-frequency loss of b capsule expression in Haemophilus influenzae. Infect Immun (1985) 2.84
Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest (1972) 2.81
Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J Clin Invest (1975) 2.48
Experimental Haemophilus influenzae type b meningitis: immunological investigation of the infant rat model. Infect Immun (1978) 2.46
Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens. J Clin Invest (1980) 2.42
Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1. Infect Immun (1977) 2.39
Differential complement resistance mediates virulence of Haemophilus influenzae type b. Infect Immun (1982) 2.23
Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins. J Clin Invest (1985) 2.09
Loss of capsule expression by Haemophilus influenzae type b results in enhanced adherence to and invasion of human cells. Infect Immun (1991) 2.02
The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94
Human antibody response to individual outer membrane proteins of Haemophilus influenzae type b. Infect Immun (1982) 1.83
Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b. Infect Immun (1987) 1.82
Characterization of the genetic locus encoding Haemophilus influenzae type b surface fibrils. J Bacteriol (1996) 1.81
Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia. Infect Immun (1983) 1.78
Genes involved in Haemophilus influenzae type b capsule expression are part of an 18-kilobase tandem duplication. Proc Natl Acad Sci U S A (1986) 1.76
Nutritional immunity. Escape from bacterial iron piracy through rapid evolution of transferrin. Science (2014) 1.74
Capsulation and gene copy number at the cap locus of Haemophilus influenzae type b. J Bacteriol (1988) 1.67
Structure of the outer membrane translocator domain of the Haemophilus influenzae Hia trimeric autotransporter. EMBO J (2006) 1.64
Composition and antigenic activity of the oligosaccharide moiety of Haemophilus influenzae type b lipooligosaccharide. Infect Immun (1985) 1.62
Variation in expression of the Haemophilus influenzae HMW adhesins: a prokaryotic system reminiscent of eukaryotes. Proc Natl Acad Sci U S A (1999) 1.60
Significance of noncapsular antigens in protection against experimental Haemophilus influenzae type b disease: cross-reactivity. Infect Immun (1978) 1.58
Activation of the alternative complement pathway by Haemophilus influenzae type B. Infect Immun (1977) 1.46
Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev (1993) 1.45
The HMW1 adhesin of nontypeable Haemophilus influenzae recognizes sialylated glycoprotein receptors on cultured human epithelial cells. Infect Immun (1994) 1.44
Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin. Infect Immun (1980) 1.44
Immunoprotective activity of ribosomes from Haemophilus influenzae. Infect Immun (1977) 1.44
Virulence factors of Haemophilus ducreyi. Infect Immun (1984) 1.41
Isolation of the capsular polysaccharide from culture supernatant of Haemophilus influenzae type b. Infect Immun (1977) 1.40
Haemophilus influenzae type b conjugate vaccines. Immunology (2004) 1.37
Adhesin expression in matched nasopharyngeal and middle ear isolates of nontypeable Haemophilus influenzae from children with acute otitis media. Infect Immun (1999) 1.36
Characterization and virulence analysis of catalase mutants of Haemophilus influenzae. Infect Immun (1994) 1.34
The Haemophilus influenzae Hap autotransporter binds to fibronectin, laminin, and collagen IV. Infect Immun (2002) 1.32
Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates. Infect Immun (1995) 1.32
Heteroimmunization to the capsular polysaccharide of Haemophilus influenzae type b induced by enteric cross-reacting bacteria. Infect Immun (1975) 1.30
Separation of serum bactericidal and opsonizing activities for Haemophilus influenzae type b. Infect Immun (1973) 1.27
Enhanced nasopharyngeal colonization of rats by piliated Haemophilus influenzae type b. Infect Immun (1985) 1.24
Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent. J Clin Microbiol (1980) 1.24
Antibody-dependent alternative pathway killing of Haemophilus influenzae type b. Infect Immun (1984) 1.24
Immunology of the infant rat experimental model of Haemophilus influenzae type b meningitis. Infect Immun (1977) 1.22
Inability to express fimbriae results in impaired ability of Haemophilus influenzae b to colonize the nasopharynx. Infect Immun (1991) 1.22
Antigenic heterogeneity of immunoglobulin A1 proteases from encapsulated and non-encapsulated Haemophilus influenzae. Infect Immun (1983) 1.22
Architecture and adhesive activity of the Haemophilus influenzae Hsf adhesin. J Bacteriol (2005) 1.22
Prevalence of the hifBC, hmw1A, hmw2A, hmwC, and hia Genes in Haemophilus influenzae Isolates. J Clin Microbiol (2004) 1.19
Variable quantitation of Haemophilus influenzae type b anticapsular antibody by radioantigen binding assay. J Clin Microbiol (1988) 1.18
Serum resistance in an invasive, nontypeable Haemophilus influenzae strain. Infect Immun (2001) 1.18
Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid. J Exp Med (2010) 1.15
Synthesis and release of polyribophosphate by Haemophilus influenzae type b in vitro. Infect Immun (1976) 1.15
Comparison of two antigen detection techniques in a primate model of Haemophilus influenzae type b infection. Infect Immun (1979) 1.15
Surface structures and adherence properties of diverse strains of Haemophilus influenzae biogroup aegyptius. Infect Immun (1991) 1.14
The Haemophilus influenzae HMW1C protein is a glycosyltransferase that transfers hexose residues to asparagine sites in the HMW1 adhesin. PLoS Pathog (2010) 1.14
Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis. Infect Immun (1984) 1.12
Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations. Clin Diagn Lab Immunol (2004) 1.11
Beta-lactamase effect on ampicillin treatment of Haemophilus influenzae B bacteremia and meningitis in infant rats. Antimicrob Agents Chemother (1977) 1.11
A major crossreactive idiotype associated with human antibodies to the Haemophilus influenzae b polysaccharide. Expression in relation to age and immunoglobulin G subclass. J Clin Invest (1990) 1.11
Serum opsonic activity after immunization of adults with Haemophilus influenzae type b-diphtheria toxoid conjugate vaccine. Infect Immun (1985) 1.09
Lipopolysaccharide subtypes of Haemophilus influenzae type b from an outbreak of invasive disease. J Clin Microbiol (1984) 1.09
Mutations affecting expression and maintenance of genes encoding the serotype b capsule of Haemophilus influenzae. J Bacteriol (1986) 1.07
Lipopolysaccharide gel profiles of Haemophilus influenzae type b are not stable epidemiologic markers. J Clin Microbiol (1986) 1.07
Enzyme-linked immunosorbent assay for detection of Haemophilus influenzae type b antigen. J Clin Microbiol (1980) 1.05
Altered lipopolysaccharide characteristic of the I69 phenotype in Haemophilus influenzae results from mutations in a novel gene, isn. J Bacteriol (1996) 1.04
Haemophilus influenzae b infection in rats: effect of splenectomy on bloodstream and meningeal invasion after intravenous and intranasal inoculations. Infect Immun (1980) 1.03
Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proc Natl Acad Sci U S A (1998) 1.03
Evidence for in vivo expression of transferrin-binding proteins in Haemophilus influenzae type b. Infect Immun (1992) 1.03
The Haemophilus influenzae Type b hcsA and hcsB gene products facilitate transport of capsular polysaccharide across the outer membrane and are essential for virulence. J Bacteriol (2006) 1.03
The periplasmic disulfide oxidoreductase DsbA contributes to Haemophilus influenzae pathogenesis. Infect Immun (2008) 1.02
Identification of phosphorylated 3-deoxy-manno-octulosonic acid as a component of Haemophilus influenzae lipopolysaccharide. Biochem J (1987) 1.00
Elaboration of type b capsule by Haemophilus influenzae as a determinant of pathogenicity and impaired killing by trimethoprim-sulfamethoxazole. J Clin Invest (1982) 1.00
Ferrochelatase activity and protoporphyrin IX utilization in Haemophilus influenzae. J Bacteriol (1995) 1.00
Mutations in polI but not mutSLH destabilize Haemophilus influenzae tetranucleotide repeats. EMBO J (2002) 0.99
Chromosomal expression of the Haemophilus influenzae Hap autotransporter allows fine-tuned regulation of adhesive potential via inhibition of intermolecular autoproteolysis. J Bacteriol (2003) 0.98
Effect of amplification of the Cap b locus on complement-mediated bacteriolysis and opsonization of type b Haemophilus influenzae. Infect Immun (1996) 0.96
Comparison of passive hemagglutination, bactericidal activity, and radioimmunological methods in measuring antibody responses to Neisseria meningitidis group A capsular polysaccharide vaccine. J Clin Microbiol (1980) 0.95
Bactericidal antibodies against noncapsular components of Haemophilus influenzae. J Clin Microbiol (1983) 0.94
Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate. Infect Immun (1997) 0.94
Position-based scanning for comparative genomics and identification of genetic islands in Haemophilus influenzae type b. Infect Immun (2003) 0.92
Functional capacities of clonal antibodies to Haemophilus influenzae type b polysaccharide. Infect Immun (1995) 0.89
Isolation, expression, and nucleotide sequencing of the pilin structural gene of the Brazilian purpuric fever clone of Haemophilus influenzae biogroup aegyptius. Infect Immun (1993) 0.89
Integration of plasmid DNA coding for beta-lactamase production in the Haemophilus influenzae chromosome. J Bacteriol (1984) 0.89
Quantitative flow cytometric analysis of opsonophagocytosis and killing of nonencapsulated Haemophilus influenzae by human polymorphonuclear leukocytes. Clin Diagn Lab Immunol (1994) 0.88
Participation of complement in host defense against capsule-deficient Haemophilus influenzae. Infect Immun (1983) 0.88
Effect of complement depletion on anticapsular-antibody-mediated immunity to experimental infection with Haemophilus influenzae type b. Infect Immun (1987) 0.87
Pathophysiology of hemolysis in infections with Hemophilus influenzae type b. J Clin Invest (1986) 0.87
Structural determinants of autoproteolysis of the Haemophilus influenzae Hap autotransporter. Infect Immun (2009) 0.86
Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence. J Clin Microbiol (1981) 0.85
Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom. Clin Vaccine Immunol (2008) 0.85
Identification and characterization of a serotype b-specific segment of the Haemophilus influenzae genome. Infect Immun (1989) 0.85
Mutations in Haemophilus influenzae mismatch repair genes increase mutation rates of dinucleotide repeat tracts but not dinucleotide repeat-driven pilin phase variation rates. J Bacteriol (2004) 0.84
Phagocytosis. Clinical disorders of recognition and ingestion. Am J Pathol (1977) 0.84
Preparation of a nontoxic and immunogenic polysaccharide fraction from a Haemophilus influenzae phenol-water extract. Infect Immun (1980) 0.84
Inactivation of Haemophilus influenzae lipopolysaccharide biosynthesis genes interferes with outer membrane localization of the hap autotransporter. J Bacteriol (2012) 0.84
Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med (1969) 9.01
The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors. J Exp Med (1969) 4.96
New Classification of Neisseria meningitidis by Means of Bactericidal Reactions. Infect Immun (1970) 3.88
EFFECTS OF LOW IONIC STRENGTH ON IMMUNE HEMOLYSIS. J Immunol (1963) 3.42
The gamma globulins. 3. The antibody deficiency syndromes. N Engl J Med (1966) 3.03
The Pattern of Dissociation in Hemophilus influenzae. J Bacteriol (1939) 2.83
Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest (1972) 2.81
THE BETA-1C GLOBULIN IN CHILDHOOD NEPHROTIC SYNDROME: LABORATORY DIAGNOSIS OF PROGRESSIVE GLOMERULONEPHRITIS. N Engl J Med (1965) 2.80
The clinical importance of Hemophilus influenzae infections in children. Pediatr Clin North Am (1970) 1.73
Studies on haemophilus influenzae type characteristics. Acta Pathol Microbiol Scand (1952) 1.67
Haemophilus influenzae meningitis in an adult. A study of bactericidal antibodies and immunoglobulins. N Engl J Med (1970) 1.58
The type-specific substance of Hemophilus influenzae, type d: the natural occurrence of glucosamine uronic acid. J Biol Chem (1963) 1.56
Studies on type-specific substances of Hemophilus influenzae, types e and f. J Biol Chem (1961) 1.44
A Type d Strain of Hemophilus influenzae Previously Designated Provisionally as Type d(2) and Type g. J Bacteriol (1947) 1.23
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol (1988) 12.52
Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (1985) 12.08
Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol (1999) 11.77
Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell (1987) 11.56
Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell (1987) 11.15
RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J Cell Biol (1999) 8.07
The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. J Clin Invest (1975) 7.40
Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) (2000) 7.17
Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med (1978) 6.50
A rapid chemical assay for gentamicin. N Engl J Med (1972) 6.36
Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Biochem Soc Trans (2002) 6.08
Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J Cell Biol (2000) 5.99
mRNA surveillance by the Caenorhabditis elegans smg genes. Genes Dev (1993) 5.94
Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature (1983) 5.90
Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infect Immun (1980) 5.68
A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell (1991) 5.65
Comparison of phenotypic and genotypic techniques for identification of unusual aerobic pathogenic gram-negative bacilli. J Clin Microbiol (1998) 5.27
Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol (1985) 5.02
Transferable R factors in enteric bacteria causing infection of the genitourinary tract. Lancet (1966) 5.01
The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors. J Exp Med (1969) 4.96
Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94
Spontaneous tandem genetic duplications in Salmonella typhimurium arise by unequal recombination between rRNA (rrn) cistrons. Proc Natl Acad Sci U S A (1981) 4.85
Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med (1999) 4.66
R factors mediate resistance to mercury, nickel, and cobalt. Science (1967) 4.57
TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J (2000) 4.41
Expression of active human factor VIII from recombinant DNA clones. Nature (1984) 4.36
Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol (1997) 4.28
Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29. Nature (1983) 4.06
Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut (2009) 4.06
Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (1984) 3.98
Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet (2001) 3.96
Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med (1984) 3.79
Marburg-virus disease in Kenya. Lancet (1982) 3.79
A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator. Mol Cell Biol (1988) 3.74
Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol (2013) 3.72
A new kind of informational suppression in the nematode Caenorhabditis elegans. Genetics (1989) 3.69
Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood (1976) 3.34
Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics (1973) 3.33
Improved enzymatic assay of chloramphenicol. Clin Chem (1978) 3.31
Generation of superoxide anion and chemiluminescence by human monocytes during phagocytosis and on contact with surface-bound immunoglobulin G. J Exp Med (1976) 3.19
SMG-2 is a phosphorylated protein required for mRNA surveillance in Caenorhabditis elegans and related to Upf1p of yeast. Mol Cell Biol (1999) 3.18
Primary structure and biochemical properties of an M2 muscarinic receptor. Science (1987) 3.16
Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J Exp Med (1980) 3.13
An abnormality of the alternate pathway of complement activation in sickle-cell disease. N Engl J Med (1973) 3.11
General practitioners and alternative medicine. J R Coll Gen Pract (1987) 3.10
Mode of action of novobiocin in Escherichia coli. J Bacteriol (1967) 3.09
Rapid diagnosis of Hemophilus influenzae type b infections by latex particle agglutination and counterimmunoelectrophoresis. J Pediatr (1978) 3.05
Life and death in the cytoplasm: messages from the 3' end. Curr Opin Genet Dev (1997) 3.01
Activation of a transposable element in the germ line but not the soma of Caenorhabditis elegans. Nature (1987) 3.00
The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. Mol Cell (2000) 2.97
Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J Exp Med (1980) 2.96
The toxicologic and pharmacologic properties of amantadine hydrochloride. Toxicol Appl Pharmacol (1969) 2.95
Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J Clin Invest (1987) 2.93
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J Clin Invest (1970) 2.92
Individual RNA recognition motifs of TIA-1 and TIAR have different RNA binding specificities. J Biol Chem (1996) 2.89
Electron microscope observations on compounds 48-80-induced degranulation in rat mast cells. Evidence for sequential exocytosis of storage granules. J Cell Biol (1971) 2.88
Identification of coryneform bacterial isolates by ribosomal DNA sequence analysis. J Clin Microbiol (2000) 2.87
Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease. J Clin Invest (1976) 2.85
Do pili play a role in pathogenicity of Haemophilus influenzae type B? Lancet (1982) 2.84
Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest (1972) 2.81
Hemophilus influenzae type B susceptibility to 17 antibiotics. J Pediatr (1975) 2.74
Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system. J Clin Invest (1981) 2.66
Preclinical evaluation of a rheolytic catheter for percutaneous coronary artery/saphenous vein graft thrombectomy. J Invasive Cardiol (1999) 2.66
Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29. Proc Natl Acad Sci U S A (1983) 2.66
Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood (1996) 2.62
Increased rate of tuberculin skin test conversion among workers at a university hospital. Infect Control Hosp Epidemiol (1992) 2.60
Inhibition of protein synthesis by spectinomycin. Science (1965) 2.54
What are safe levels of alcohol consumption? Br Med J (Clin Res Ed) (1984) 2.54
Unproductively spliced ribosomal protein mRNAs are natural targets of mRNA surveillance in C. elegans. Genes Dev (2000) 2.52
Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J Clin Invest (1975) 2.48
Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b. J Immunol (1979) 2.47
Gentamicin:adenine mononucleotide transferase: partial purification, characterization, and use in the clinical quantitation of gentamicin. J Infect Dis (1974) 2.45
The costs of treating COPD in the United States. Chest (2001) 2.43
Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens. J Clin Invest (1980) 2.42
Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J Neurosci (1992) 2.41
The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions. J Clin Invest (1975) 2.40
Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J (1987) 2.39
Identification and functional characterization of a TIA-1-related nucleolysin. Proc Natl Acad Sci U S A (1992) 2.38
Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function. Immunopharmacology (1980) 2.35
Countercurrent immunoelectrophoresis in the diagnosis of systemic diseases caused by Hemophilus infleunzae type b. J Pediatr (1972) 2.33
Transposition of Tc1 in the nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A (1985) 2.33
Role of heat-labile toxigenic Escherichia coli and Reovirus-like agent in diarrhoea in Boston children. Lancet (1975) 2.31
Studies on the epidemiology of resistance (R) factors. I. Analysis of Klebsiella isolates in a general hospital. II. A prospective study of R factor transfer in the host. Ann Intern Med (1969) 2.28
Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J Neurosci (2001) 2.28
Recovery of resistance (R) factors from a drug-free community. Lancet (1969) 2.26
Inhibition of phagocytosis-associated chemiluminescence by superoxide dismutase. Infect Immun (1974) 2.26
Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci U S A (1991) 2.24
Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest (1986) 2.22
Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect Immun (1991) 2.22
Isolation and partial characterization of outer and inner membranes from encapsulated Haemophilus influenzae type b. J Bacteriol (1981) 2.21
Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response. J Immunol (1982) 2.19
Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci. Infect Immun (2001) 2.19
The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics (1989) 2.17